Civic Intelligence

The Ftd Disorders Registry LLC

990 • Fiscal year 2021 • EIN 47-3601782

Jul 01, 2020 to Jun 30, 2021

Kng Of Prussa, PA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

41st percentile

0.03x

Higher debt load relative to assets than 41% of similar nonprofits.

2021 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2021

Liabilities / Revenue

49th percentile

0.08x

Higher debt load relative to revenue than 49% of similar nonprofits.

2021 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2021

Net Margin

64th percentile

22%

Higher net margin than 64% of similar nonprofits.

2021 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2021

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2021

Asset Growth

38th percentile

4.0%

Faster asset growth than 38% of similar nonprofits.

2021 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2020 to 2021

Revenue Growth

14th percentile

-19%

Faster revenue growth than 14% of similar nonprofits.

2021 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2020 to 2021

Assets

Up

$1,129,264

Up $43,212 (+4.0%) from 2020

Net Assets

Up

$1,092,206

Up $94,553 (+9.5%) from 2020

Liabilities

Down

$37,058

Down $51,341 (-58%) from 2020

Revenue

Down

$439,215

Down $104,369 (-19%) from 2020

Expenses

Down

$344,662

Down $403,290 (-54%) from 2020

Net Income

Up

$94,553

Up $298,921 (+146%) from 2020

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$3.0M$2.0M$1.0M$0Assets 2015: $472,062Liabilities 2015: $15,946Net Assets 2015: $456,1162015Assets 2016: $515,815Liabilities 2016: $14,993Net Assets 2016: $500,8222016Assets 2017: $875,990Liabilities 2017: $17,912Net Assets 2017: $858,0782017Assets 2018: $1,008,189Liabilities 2018: $30,337Net Assets 2018: $977,8522018Assets 2019: $1,250,745Liabilities 2019: $48,724Net Assets 2019: $1,202,0212019Assets 2020: $1,086,052Liabilities 2020: $88,399Net Assets 2020: $997,6532020Assets 2021: $1,129,264Liabilities 2021: $37,058Net Assets 2021: $1,092,2062021Assets 2022: $1,122,791Liabilities 2022: $37,184Net Assets 2022: $1,085,6072022Assets 2023: $2,043,499Liabilities 2023: $116,119Net Assets 2023: $1,927,3802023Assets 2024: $2,410,986Liabilities 2024: $407,302Net Assets 2024: $2,003,6842024Assets 2025: $2,218,789Liabilities 2025: $236,444Net Assets 2025: $1,982,3452025

Highlighted filing

2021

Assets$1,129,264
Liabilities$37,058
Net Assets$1,092,206

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$2.0M$1.5M$1.0M$500K$0-$500KRevenue 2015: $358,325Expenses 2015: $77,209Net Income 2015: $281,1162015Revenue 2016: $234,540Expenses 2016: $264,834Net Income 2016: -$30,2942016Revenue 2017: $611,229Expenses 2017: $303,973Net Income 2017: $307,2562017Revenue 2018: $489,156Expenses 2018: $369,382Net Income 2018: $119,7742018Revenue 2019: $762,008Expenses 2019: $537,839Net Income 2019: $224,1692019Revenue 2020: $543,584Expenses 2020: $747,952Net Income 2020: -$204,3682020Revenue 2021: $439,215Expenses 2021: $344,662Net Income 2021: $94,5532021Revenue 2022: $727,717Expenses 2022: $734,316Net Income 2022: -$6,5992022Revenue 2023: $1,600,782Expenses 2023: $759,009Net Income 2023: $841,7732023Revenue 2024: $1,031,597Expenses 2024: $955,293Net Income 2024: $76,3042024Revenue 2025: $871,164Expenses 2025: $892,503Net Income 2025: -$21,3392025

Highlighted filing

2021

Revenue$439,215
Expenses$344,662
Net Income$94,553
Filing Detail Status

This 2021 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jul 1, 2020 to Jun 30, 2021
Mission and Program Overview

Mission

The registry's mission is to facilitate research and advance research to accelerate treatment development for all types of ftd, a devastating neurodegenerative disease that strikes people in the prime of life and for which, currently, there is no cure.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings